Clinical manifestations, diagnosis, and treatment of neurocysticercosis

Current Neurology and Neuroscience Reports

Volumn 11, Issue 6, 2011, Pages 529-535

  Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Albendazole; Cysticercosis; Epilepsy; Hydrocephalus; Neurocysticercosis; Praziquantel; Serodiagnosis; Taeniasis

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PRAZIQUANTEL; PREDNISONE; STEROID;

ARACHNOIDITIS; ARTICLE; BRAIN SURGERY; CESTODE LIFE CYCLE STAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG CEREBROSPINAL FLUID LEVEL; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; ENDEMIC DISEASE; ENVIRONMENTAL SANITATION; EPILEPSY; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; HYDROCEPHALUS; INFLAMMATION; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PARASITE PREVALENCE; PATIENT COMPLIANCE; SEIZURE; SINGLE DRUG DOSE; TAENIA SOLIUM;

ANIMALS; ANTHELMINTICS; HUMANS; INFLAMMATION; NEUROCYSTICERCOSIS; NEUROSURGICAL PROCEDURES; TAENIA SOLIUM;

EID: 81155152243     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0226-7     Document Type: Article

References (47)

1. H Garcia OH Del Bruto 2005 Neurocysticercosis: updated concepts about an old disease Lancet Neurol 4 653 661 16168934 10.1016/S1474-4422(05)70194-0 (Pubitemid 41317300)
2. F Quet M Guerchet SD Pion, et al. 2010 Meta-analysis of the association between cysticercosis and epilepsy in Africa Epilepsia 51 830 837 19919664
3. S Sinha BS Sharma 2009 Neurocysticercosis: a review of current status and management J ClinNeurosci 16 867 876 10.1016/j.jocn.2008.10.030 This review is practical and comprehensive with figures and photographs that clearly exemplify the complex pathophysiology of NCC and it includes a good selection of relevant references too
4. FJ Sorvillo C DeGiorgio SH Waterman 2007 Deaths from Cysticercosis, United States Emerg Infect Dis 13 230 235 17479884 10.3201/eid1302.060527 (Pubitemid 46193165)
5. F Sorvillo P Wilkins S Shafir, et al. 2011 Public health implications of cysticercosis acquired in the United States Emerg Infect Dis 17 1 6 21192847 10.3201/eid1701.101210
6. •• Coyle CM, Tanowitz HB. Diagnosis and Treatment of Neurocysticercosis. Interdiscip Perspect Infect Dis 2009, 2009: doi: 10.1155/2009/180742. This is a thoroughly comprehensive and updated review that joins classical and modern concepts on the evolving field of NCC, particularly in regard to therapeutics.
7. C Croker R Reporter L Mascola 2010 Use of Statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991-2008) Am J Trop Med Hyg 83 106 110 20595487 10.4269/ajtmh.2010.09-0494
8. NE Holmes LE Iles RA Danks, et al. 2010 Neurocysticercosis causing sudden death Am J Forensic Med Pathol 31 117 119 20139756 10.1097/PAF.0b013e3181cfc8a3
9. P Salgado R Rojas J Sotelo 1997 Clinical classification based on imaging studies Arch Intern Med 157 1991 1997 9308511 10.1001/archinte.157.17.1991 1:STN:280:DyaK2svltlyqsw%3D%3D (Pubitemid 27398363)
10. J Sotelo F Escobedo J Rodríguez, et al. 1984 Therapy of parenchymal brain cysticercosis with praziquantel N Engl J Med 310 1001 1007 6708975 10.1056/NEJM198404193101601 1:STN:280:DyaL2c7mvVSjsg%3D%3D (Pubitemid 14129232)
11. F Escobedo P Penagos J Rodríguez, et al. 1987 Albendazole therapy for neurocysticercosis Arch Intern Med 147 738 741 3827462 10.1001/archinte.147. 4.738 1:STN:280:DyaL2s7lsFOjsw%3D%3D (Pubitemid 17063559)
12. J Sotelo C Diaz-Olavarrieta 2010 Neurocysticercosis: changes after 25 years of medical therapy Arch Med Res 41 62 63 20430257 10.1016/j.arcmed.2009. 12.003
13. J Sotelo 2003 Neurocysticercosis. Eradication of cysticercosis is an attainable goal BMJ 326 511 512 12623885 10.1136/bmj.326.7388.511
14. J Sotelo V Guerrero F Rubio 1985 Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases Arch Intern Med 145 442 445 3977513 10.1001/archinte.145.3.442 1:STN:280:DyaL2M7kvVanuw%3D%3D (Pubitemid 15140738)
15. D Ciampi de Andrade CL Rodrigues R Abraham, et al. 2010 Cognitive impairment and dementia in neurocysticercosis Neurology 74 1288 1295 20404310 10.1212/WNL.0b013e3181d9eda6 1:STN:280:DC%2BC3c3nsVensA%3D%3D
16. T Kelesidis S Tsiodras 2011 Hypopituitarism caused by Neurocysticercosis Am J Med Sci 341 414 416 21289508 10.1097/MAJ.0b013e3182056438
17. T Jayaraman V Prabhakaran P Babu, et al. 2011 Relative seroprevalence of cysticercus antigens and antibodies and antibodies to Taenia ova in a population sample in south India suggest immunity against neurocysticercosis Trans R Soc Trop Med Hyg 105 153 159 21216417 10.1016/j.trstmh.2010.10.007 1:STN:280:DC%2BC3M3hsVSqtQ%3D%3D
18. N Praet N Speybroeck R Rodriguez-Hidalgo, et al. 2010 Age-related infection and transmission patterns of human cysticercosis Int J Parasitol 40 85 90 19683531 10.1016/j.ijpara.2009.07.007 1:CAS:528:DC%2BD1MXhsFyns7rM
19. HH García AE Gonzalez S Rodriguez, et al. 2010 Neurocysticercosis: unraveling the nature of the single cysticercal granuloma Neurology 75 654 658 20713953 10.1212/WNL.0b013e3181ed9eae
20. V Rajshekar 2010 Surgical management of neurocysticercosis Int J Surg 8 100 104 10.1016/j.ijsu.2009.12.006 This review represents a well-documented status on the surgical aspects of NCC, and it offers an equilibrated view of surgical options in addition to drug therapy
21. A Fleury R Carrillo-Mezo A Flisser, et al. 2011 Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease Expert Rev Anti Infect Ther 9 123 133 21171883 10.1586/eri.10.150
22. J Moskowitz G Mendelsohn 2010 Neurocysticercosis Arch Pathol Lab Med 134 1560 1563 20923314 This is a brief summary of important facts about NCC
23. PC Ndimubanzi H Carabin CM Budke, et al. 2010 A systemic review of the frequency of neurocysticercosis with a focus on people with epilepsy PLos Negl Trop Dis 4 e870 10:1371/journal.pntd.0000870 21072231 10.1371/journal.pntd. 0000870
24. AS Winkler AL Willingham 3rd CS Sikasunge, et al. 2009 Epilepsy and neurocysticercosis in sub-Saharan Africa Wien Klin Wochenschr 3 3 12 10.1007/s00508-009-1242-3
25. MV Raghava V Prabhakaran T Jayaraman, et al. 2010 Detecting spatial clusters of Taenia solium infections in a rural block in South India Trans R Soc Trop Med Hyg 104 601 612 20638091 10.1016/j.trstmh.2010.06.002
26. AM Alexander V Prabhakaran V Rajshekhar, et al. 2010 Long-term clinical evaluation of asymptomatic subjects positive for circulating Taenia solium antigens Trans R Soc Trop Med Hyg 104 809 810 20801473 10.1016/j.trstmh.2010.07. 005 1:STN:280:DC%2BC3cbmslWiuw%3D%3D
27. J Lundström F Salazar-Anton E Sherwood, et al. 2010 Analyses of an expressed sequence tag library from Taeniasolium, Cysticerca PLoS Negl Trop Dis 4 e919 10.1371/journal.pntd.0000919 21200421 10.1371/journal.pntd.0000919
28. P Kaur P Dhiman N Dhawan, et al. 2010 Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion Neurol India 58 560 564 20739792 10.4103/0028-3886.68677
29. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010, doi: 10.1002/14651858. CD000215.pub4.
30. J Sotelo 2004 Neurocysticercosis: is the elimination of parasites beneficial? N Engl J Med 350 280 282 14724309 10.1056/NEJMe038218 1:CAS:528:DC%2BD2cXltVSltQ%3D%3D (Pubitemid 38067642)
31. J Uddin AE Gonzalez RH Gilman, et al. 2010 Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy J Immunol 185 4478 4484 20826750 10.4049/jimmunol.0904158 1:CAS:528: DC%2BC3cXhtFyis7%2FO
32. D Goel M Mittal KK Bansal, et al. 2010 Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India Acta Neurol Scand 121 204 208 19951271 10.1111/j.1600-0404. 2009.01180.x 1:CAS:528:DC%2BC3cXjtVSlsb8%3D
33. A Ramírez-Zamora T Alarcón 2010 Management of neurocysticercosis Neurol Res 32 229 237 20406600 10.1179/ 016164110X12644252260592
34. RN Chaurasia RK Garg A Agarwall, et al. 2010 Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study Southeast Asian J Trop Med Public Health 41 517 525 20578537
35. J Sotelo H Jung 1998 Pharmacokinetic optimisation of the treatment of neurocysticercosis Clin Pharmacokinet 34 503 515 9646011 10.2165/00003088- 199834060-00006 1:CAS:528:DyaK1cXkt1eisrY%3D (Pubitemid 28271899)
36. S Mahanty A Paredes M Marzal, et al. 2011 A sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts Antimicrob Agents Chemother 55 211 217 21041508 10.1128/AAC.00761-10 1:CAS:528:DC%2BC3MXisVehu7s%3D
37. BB Mishra UM Gundra JM Teale 2009 Toll-like receptors in CNS parasitic infections Curr Top Microbiol Immunol 336 83 104 19688329 10.1007/978-3-642- 00549-7-5 1:CAS:528:DC%2BC3cXisVamtrg%3D
38. J Sotelo N Arriada MA Lopez 2005 Ventriculoperitoneal shunt of continuous flow vs valvular shunt for treatment of hydrocephalus in adults Surg Neurol 63 197 203 15734497 10.1016/j.surneu.2004.07.040 (Pubitemid 40278990)
39. A De Souza K Thennarasu G Yeshraj, et al. 2009 Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome J Neurol Sci 276 108 114 18851861 10.1016/j.jns.2008.09.010
40. JV Proaño J Torres-Corzo R Rodríguez-Della Vecchia, et al. 2009 Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery Childs Nerv Syst 25 1467 75 19557421 10.1007/s00381-009-0933-4
41. JG Torres-Corzo JH Tapia-Pérez RR Vechhia, et al. 2010 Endoscopic management of hydrocephalus due to neurocysticercosis Clin Neurol Neurosurg 112 11 16 19767141 10.1016/j.clineuro.2009.08.022
42. A Flisser D Correa 2010 Neurocysticercosis may no longer be a public health problem in Mexico PLoS Negl Trop Dis 4 e831 10.1371/journal.pntd.0000831 21200418 10.1371/journal.pntd.0000831
43. A Fleury J Moreno Garcia P Valdez Aguerrebere, et al. 2010 Neurocysticercosis, a persisting health problem in Mexico PLoS Negl Trop Dis 4 e805 10.1371/journal.pntd.0000805 20808759 10.1371/journal.pntd.0000805
44. Pybus M, Heron P. Neurocysticercosis: An unusual cause of seizure in the New Zealand setting. J Paediatr Child Health 2011, doi: 10.1111/j.1440-1754. 2010.01971.x
45. S Moroni G Moscatelli H Freilij, et al. 2010 Neurocysticercosis: report of an autochthonous case in Buenos Aires city Arch Argent Pediatr 108 e143 146 21132241
46. Medina MT, Aguilar-Estrada RL, Alvarez A, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: The Salamá, Honduras study. Epilepsia 2011, doi: 10.1111/j.1528-1167.2010.02945.x.
47. AL Willingham 3rd HW Wu J Conian, et al. 2010 Combating Taenia solium cysticercosis in Southeast Asia an opportunity for improving human health and livestock production Adv Parasitol 72 235 266 20624534 10.1016/S0065-308X(10) 72009-1